<!--[if (gte mso 9)|(IE)]>

<![endif]-->

<!--[if (gte mso 9)|(IE)]>

<![endif]-->

<!--[if (gte mso 9)|(IE)]>

<![endif]-->

<!--[if (gte mso 9)|(IE)]>

<![endif]-->

<!--[if (gte mso 9)|(IE)]>

<![endif]--> <!--[if (gte mso 9)|(IE)]>

<![endif]-->

<!--[if (gte mso 9)|(IE)]>

<![endif]-->

MedWatch – The FDA Safety Information and Adverse Event Reporting Program

<!--[if (gte mso 9)|(IE)]>

<![endif]-->

<!--[if (gte mso 9)|(IE)]>

<![endif]--> <!--[if (gte mso 9)|(IE)]>

<![endif]-->

<!--[if (gte mso 9)|(IE)]>

<![endif]-->

Reminder: Provide Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample: Letter to Health Care Providers

The U.S. Food and Drug Administration (FDA) reminds health care providers to give clear, step-by-step instructions to patients who, in a health care setting, self-collect anterior nasal samples for SARS-CoV-2 testing. Without proper instructions, patients may not collect an adequate sample for testing, which may decrease the sensitivity of the test.

The Letter to Health Care Providers includes:

Details for providing patients with clear instructions for performing anterior nares (nasal) sample self-collection in a health care setting.
Recommendations for health care providers.
Suggested resources on testing for SARS-CoV-2.
Instructions for reporting problems with SARS-CoV-2 testing.

Questions?

If you have questions about this Letter to Health Care Providers, email COVID19DX@fda.hhs.gov.

<!--[if (gte mso 9)|(IE)]>

<![endif]-->

<!--[if (gte mso 9)|(IE)]>

<![endif]-->

<!--[if mso]>

<![endif]-->

Leave a Reply Cancel reply
Your email address will not be published. Required fields are marked *
Comment *
Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Post navigation

Previous Post Recall Expansion of Durisan Non-Alcohol Hand Sanitizer
Next Post Miracle8989 Issues Voluntary Nationwide Recall of PremierZen Gold 7000, PremierZen Platinum 8000 and MaxxZEN Platinum 12000, Due to Presence of Undeclared Sildenafil and Tadalafil

Search for:

Recent Posts

Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses

Boulla LLC Issues Voluntary Nationwide Recall of ZoomMax and ZapMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac

Savencia Cheese USA Announces an Expanded Voluntary Recall of Select Soft Ripened Cheeses

HH Fresh Trading Corp Recalls Taiwan Enoki 200gx25pk Because of Possible Health Risk

FDA MedWatch – Compunded Drugs by Fullerton Wellness

Proudly powered by WordPress